Try our Advanced Search for more refined results

In Re: Prempro Products et al

Track this case

Case overview

Case Number:

4:03-cv-01507

Court:

Arkansas Eastern

Nature of Suit:

Personal Inj. Prod. Liability

Judge:

Billy Roy Wilson

Firms

Companies

Sectors & Industries:

  1. January 14, 2009

    Wyeth, Pfizer Push To Get Prempro MDL Tossed

    A group of drugmakers, including Wyeth Pharmaceuticals Inc., Bristol-Myers Squibb Co. and Pfizer Inc., struck a defiant tone Monday in a massive multidistrict litigation accusing them of advertising and selling hormone treatments that cause breast cancer, denying all allegations and asking for the case to be dismissed.

  2. December 29, 2008

    9 Defendants Dismissed From Prempro Suits

    A federal judge has dismissed several defendants from more than 75 cases that are part of the multidistrict product liability litigation over Wyeth Pharmaceutical Inc.'s drug Prempro and related hormone-replacement drugs.

  3. November 07, 2008

    Wyeth, Pfizer Face More Claims In Premarin Suit

    Plantiffs in the multidistrict litigation alleging that Premarin and similar estrogen hormone-replacement drugs led to their breast cancer filed a motion Thursday to add further claims against Wyeth Inc. and Pfizer Inc. to the complaint based on new scientific data previously unavailable.

  4. June 10, 2008

    Wyeth Calls For Ousting Of Lawyers In Prempro MDL

    Wyeth Pharmaceuticals Inc. has called for the removal of two lawyers from the steering committee of plaintiffs in multidistrict litigation over its hormone pills Prempro and Premarin, accusing the pair of trying to “end-run” the proceedings by re-serving withdrawn discovery requests in a different court.

  5. May 20, 2008

    Wyeth Calls For End To Discovery In Prempro MDL

    Wyeth Pharmaceuticals Inc. has urged a federal judge to set a deadline for generic discovery in the multidistrict proceedings over its hormone pills, saying the speedy resolution of the litigation required an end to the drawn-out pretrial phase.

  6. October 12, 2007

    Lawyers Want Wyeth To Hand Over Documents

    Plaintiff attorneys in the multidistrict litigation alleging Prempro and Premarin caused patients to develop breast cancer are trying to get a judge to force Wyeth Pharmaceuticals Inc. to hand over correspondence with the U.S. Food and Drug Administration regarding label changes to the hormone replacement drugs.

  7. August 20, 2007

    Wyeth Fights Prempro Plaintiffs' Latest Discovery Bids

    Wyeth Inc. has rejected a recent set of discovery requests by plaintiffs in the multidistrict litigation over Prempro, arguing that the bid for the documents is “unrealistic” and “obviously burdensome.”

  8. August 13, 2007

    Wyeth Wants Prempro Records Preserved

    Wyeth Inc. has asked a federal judge to make sure the medical records of plaintiffs in the multidistrict litigation over Prempro are preserved, arguing that the information is “of critical importance” to plaintiffs and defendants alike.

  9. August 03, 2007

    Judge Limits Discovery in Prempro MDL

    In the multidistrict litigation over the hormone replacement therapy Prempro, a federal judge ordered pharmaceutical giant Wyeth on Thursday to turn over all notes made by sales representatives both before and during the time plaintiffs were prescribed the medication to alleviate symptoms relating to menopause.

  10. July 05, 2007

    Prempro Judge OKs Case-Specific Discovery

    A judge overseeing the multidistrict litigation over Wyeth's Prempro has ruled that case-specific discovery should still go forward for individual plaintiffs who allege the pharmaceutical company's hormone drug caused breast cancer.